Investor Presentaiton
Robust financial profile¹
CFS' Income has grown steadily...
Revenues (INR mn)
...with improving EBITDA margins...
EBITDA margin (%)
...that has led to healthy operating cash flows
19.1%
600
5,583
16.2%
5,087
4,893
400
14.9%
13.8%
3,736
12.0%
200
3,352
0
CFO (INR mn)
556
463
267
(200)
(400)
(319)
FY12
FY13
FY14
FY15
FY12
FY13
FY14
FY15
FY16
FY12
FY13
FY14
FY15
FY16
It has consistently reduced leverage...
Debt/Equity ratio
...even while increasing asset base...
Net Fixed Assets
...thus supporting improvement in its ratios
ROCE
2.4
1.9
1.6
1,052
1,092
1.2
840
761
0.9
1,653
25%
20%
15%
10%
5%
0%
FY12
FY13
FY14
FY15
FY16
FY12
FY13
FY14
FY15
FY162
FY12
FY13
FY14
FY15
FY162
CFS aims to increase its profitability further, by moving up the value chain and increased capacity utilization
1 Consolidated financials;
2 Total debt for FY12-FY15 includes current portion of LT Debt; for FY16 the debt number doesn't include the current portion of LT Debt
ROCE is calculated as EBIT/Average Capital Employed; EBITDA includes Other Income and margins are calculated on gross basis
CFS Camlin
Fine Sciences
15View entire presentation